Loading
A phase 1/2 trial of liposomal irinotecan, cAPOX (capecitabine, oxaliplatin), fluorouracil (5-FU) and fLOT (5-FU, leucovorin, oxaliplatin, docetaxel) in pancreatic cancer, run by Tianjin Medical University Cancer Institute and Hospital, not yet recruiting.
Stereotactic Body Radiation Therapy Followed by NALIRIFOX vs NALIRIFOX for Borderline Resectable Pancreatic Cancer is a phase 1/2, randomised interventional study registered as NCT06259058 by Tianjin Medical University Cancer Institute and Hospital, with a registry enrolment figure of 96 participants, started 2024-04-01 and due to reach its primary completion in 2026-04-01. Interventions recorded: Irinotecan liposome injection; Oxaliplatin; 5-Fluorouracil; Leucovorin; SBRT. Conditions listed: Pancreatic Cancer. Primary outcome: R0 resection rate. Pancreatic eligibility wording from the registry: "* Histologically or cytologically proven pancreatic ductal adenocarcinoma". No results are recorded here; the registry entry is the source.
Shares Liposomal irinotecan, CAPOX (capecitabine, oxaliplatin), Fluorouracil (5-FU), Resectable pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Fluorouracil (5-FU) and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, CAPOX (capecitabine, oxaliplatin), Fluorouracil (5-FU), Resectable pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Borderline resectable pancreatic ductal adenocarcinoma, Fluorouracil (5-FU) and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), Fluorouracil (5-FU), Topoisomerase-I inhibitors (and ADC payloads) and the tag pancreatic-deep-dive.
Shares FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), CAPOX (capecitabine, oxaliplatin), Borderline resectable pancreatic ductal adenocarcinoma, Resectable pancreatic ductal adenocarcinoma and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, CAPOX (capecitabine, oxaliplatin), Resectable pancreatic ductal adenocarcinoma, Topoisomerase-I inhibitors (and ADC payloads) and the tag pancreatic-deep-dive.
Shares Liposomal irinotecan, FLOT (5-FU, leucovorin, oxaliplatin, docetaxel), Fluorouracil (5-FU), Topoisomerase-I inhibitors (and ADC payloads) and the tag pancreatic-deep-dive.